NEW YORK, June 23, 2011 /PRNewswire/ -- Life sciences companies in the U.S. raised $53 million through activity of 19 at-the-market (ATM) offerings of common stock in the first quarter of this year, according to data released today from Brinson Patrick Securities Corporation. The dollar amount represents a 32% increase in the use of ATMs in the life sciences sector compared to the first quarter of 2010. Four new ATMs were activated in the first quarter, 2011, and six new ATMs so far in the second quarter, 2011.
Life science companies that utilized ATMs to raise capital in the first quarter include: AEterna Zentaris Inc. (NASDAQ: AEZS), Quebec City, Quebec; Biolase (NASDAQ: BLTI), Irvine, Calif.; Novavax (NASDAQ: NVAX), Rockville, Md.; and Zalicus (NASDAQ: ZLCS), Cambridge, Mass.
"ATM activity continued its strong growth trend during the first quarter," commented Todd Wyche, founder and managing director of Brinson Patrick. "CFOs from life science companies continue to look for and increasingly employ fund-raising vehicles that minimize the impact from uncertainty in the capital markets and reduce the cost of raising capital. This was reflected in the ATM numbers for the first quarter."
An ATM offering provides an efficient means of raising equity capital over time by enabling a publicly traded company to tap into the existing secondary market for its shares on an as-needed basis. With an ATM, an exchange listed company incrementally sells newly issued shares into the trading market through a designated broker-dealer at prevailing market prices, rather than via a traditional underwritten offering of a fixed number of shares at a fixed price all at once.ATM offerings provide flexibility, efficiency, control, discretion and just-in-time capital with minimal dilution of stock when managed by an experienced ATM underwriter. In addition, ATMs do not dilute existing shareholders through discounting or issuing warrants, issues common to traditional capital raises. ATMs raise incremental capital over time, making them ideal for raising general working capital, funding specific projects, funding research and development, and paying off debt. ATM offerings are generally less expensive and less complicated to execute than traditional equity offerings and do not require a lot of executive time – for instance there are no required executive road shows.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV